Sort by
Refine Your Search
-
Country
-
Employer
- Zintellect
- Harvard University
- Indiana University
- Center for Drug Evaluation and Research (CDER)
- Northeastern University
- University of Michigan
- Dana-Farber Cancer Institute (DFCI)
- Missouri University of Science and Technology
- University of Kansas Medical Center
- National Center for Toxicological Research (NCTR)
- University of Texas at Austin
- Center for Biologics Evaluation and Research (CBER)
- Office of the Commissioner (OC)
- University of Arkansas
- University of Colorado
- Center for Devices and Radiological Health (CDRH)
- City of Hope
- The University of Alabama
- University of California
- University of Maryland, Baltimore
- Barnard College
- Carnegie Mellon University
- Drexel University
- Marquette University
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- The University of Chicago
- University of Michigan - Ann Arbor
- University of Notre Dame
- University of Utah
- University of Washington
- Yale University
- ADELAIDE UNIVERSITY
- Cold Spring Harbor Laboratory
- Dana-Farber Cancer Institute
- Delaware State University
- Florida Atlantic University
- Johns Hopkins University
- Lawrence Berkeley National Laboratory
- MASSACHUSETTS GENERAL HOSPITAL
- Nanyang Technological University
- New York University
- New York University Grossman School of Medicine (Torres-Vázquez lab)
- St Jude Children's Research Hospital
- Temple University
- The University of Iowa
- University of Alabama, Tuscaloosa
- University of Denver
- University of Michigan (U-M)
- University of North Carolina at Charlotte
- University of Southern California, Department of Molecular and Cellular Biosciences
- University of Texas Rio Grande Valley
- Virginia Tech
- Visterra, Inc.
- Washington University in St. Louis
- Wayne State University
- 45 more »
- « less
-
Field
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 1 day ago
regulatory science by engaging with regulatory scientists and policy experts from multiple national agencies, and will strengthen interdisciplinary competencies in areas such as analytical chemistry
-
to chemicals in the environment, the following will be helpful in achieving that goal: General environmental health science Environmental chemistry and understanding chemical analytical methods, data analysis
-
nanotechnology and polymer research relevant to FDA’s public health mission. The Nanotechnology Core Facility supports FDA mission by developing and applying state-of-the-art analytical approaches to understand
-
nanotechnology and polymer research relevant to FDA’s public health mission. The Nanotechnology Core Facility supports FDA mission by developing and applying state-of-the-art analytical approaches to understand
-
New York University Grossman School of Medicine (Torres-Vázquez lab) | New York City, New York | United States | 2 months ago
expression analyses, quantitative imaging. Excellent written and verbal communication skills. Strong quantitative and analytical skills The ability to work both independently and collaboratively in a team
-
complete application consists of: An application Transcripts – Click here for detailed information about acceptable transcripts A current resume/CV, including academic history, employment history, relevant
-
networks. Data Collection: Conduct in vivo neurophysiological recordings and behavioral assays in mice and tree shrews. Data Analysis: Process large-scale neural datasets, applying computational tools
-
degree). Degree must have been received within the past five years, or anticipated to be received by 12/31/2026. Preferred skills: Management information systems, computer programming, data analytics and
-
. Demonstrated ability to integrate hardware, software, and analytics into coherent experimental platforms. Additional information: Application date: Priority consideration will be given to candidates who apply by
-
Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 3 months ago
of the sialylated IVIG fraction from ~10–20% to =80% can produce a more potent, lower-dose item, potentially enabling a four-fold dose reduction. The project involves, developing and validating analytical methods